4//SEC Filing
ALBINI EDWARD C 4
Accession 0001415889-24-007181
CIK 0001382101other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:21 PM ET
Size
13.5 KB
Accession
0001415889-24-007181
Insider Transaction Report
Form 4
ALBINI EDWARD C
CFO AND SECRETARY
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2024-03-05+68,000→ 68,000 totalExercise: $4.54Exp: 2034-03-05→ Common Stock (68,000 underlying) - Award
Restricted Stock Units (RSUs)
2024-03-05+51,000→ 51,000 totalExp: 2028-03-01→ Common Stock (51,000 underlying) - Exercise/Conversion
Common Stock
2024-03-05+8,750→ 109,843 total - Tax Payment
Common Stock
2024-03-05$4.54/sh−3,100$14,074→ 106,743 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2024-03-05−8,750→ 8,750 totalExp: 2025-03-05→ Common Stock (8,750 underlying)
Footnotes (5)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F3]Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
- [F4]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
- [F5]The RSUs vest as to 1/4th of the total award annually beginning on March 5, 2022, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001240014
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:21 PM ET
- Size
- 13.5 KB